Pig deendothelialized coronary artery rings and smooth muscle cells cultured from them accumulated ascorbate from medium containing Na+. The accumulated material was determined to be ascorbate using high-performance liquid chromatography. We further characterized ascorbate uptake in the cultured cells. The data fitted best with a Hill coefficient of 1 for ascorbate (Kasc = 22 ± 2 μM) and 2 for Na+ (KNa = 84 ± 10 mM). The anion transport inhibitors sulfinpyrazone and 4,4′-diisothiocyanatostilbene-2,2′-disulfonate (DIDS) inhibited the uptake. Transferring cultured cells loaded with 14C-ascorbate into an ascorbate-free solution resulted in a biphasic loss of radioactivity – an initial sulfinpyrazone-insensitive faster phase and a late sulfinpyrazone-sensitive slower phase. Transferring loaded cells into a Na+-free medium increased the loss in the initial phase in a sulfinpyrazone-sensitive manner, suggesting that the ascorbate transporter is bidirectional. Including peroxide or superoxide in the solution increased the loss of radioactivity. Thus, ascorbate accumulated in coronary artery smooth muscle cells by a Na+-dependent transporter was lost in an ascorbate-free solution, and the loss was increased by removing Na+ from the medium or by oxidative stress.

1.
Liebler DC: The role of metabolism in the antioxidant function of vitamin E. Crit Rev Toxicol 1993;23:147–169.
2.
Sciamanna MA, Lee CP: Ischemia/reperfusion-induced injury of forebrain mitochondria and protection by ascorbate. Arch Biochem Biophys 1993;305:215–224.
3.
Aust SD, Chignell CF, Bray TM, Kalyanaraman B, Mason RP: Free radicals in toxicology. Toxicol Appl Pharmacol 1993;120:168–178.
4.
Mehlhorn RJ: Ascorbate- and dehydroascorbic acid-mediated reduction of free radicals in the human erythrocyte. J Biol Chem 1991;266:2724–2731.
5.
Nakamura M, Ohtaki S: Formation and reduction of ascorbate radicals by hog thyroid microsomes. Arch Biochem Biophys 1993;305:84–90.
6.
Niki E: Action of ascorbic acid as a scavenger of active and stable oxygen radicals. Am J Clin Nutr 1991;54(suppl 6):11195–11245.
7.
Constantinescu A, Han D, Packer L: Vitamin E recycling in human erythrocyte membranes. J Biol Chem 1993;268:10906–10913.
8.
Malo C, Wilson JX: Glucose modulates vitamin C transport in adult human small intestinal brush border membrane vesicles. J Nutr 2000;130:63–69.
9.
Bergsten P, Yu R, Kehrl J, Levine M: Ascorbic acid transport and distribution in human B lymphocytes. Arch Biochem Biophys 1995;317:208–214.
10.
Bowers-Komro DM, McCormick DB: Characterization of ascorbic acid uptake by isolated rat kidney cells. J Nutr 1991;121:57–64.
11.
Ek A, Strom K, Cotgreave IA: The uptake of ascorbic acid into human umbilical vein endothelial cells and its effect on oxidant insult. Biochem Pharmacol 1995;50:1339–1346.
12.
Glascott PA Jr, Gilfor E, Farber JL: Relationship of the metabolism of vitamins C and E in cultured hepatocytes treated with tert-butyl hydroperoxide. Mol Pharmacol 1995;48:80–88.
13.
Helbig H, Korbmacher C, Wohlfarth J, Berweck S, Kuhner D, Wiederholt M: Electrogenic Na+-ascorbate cotransport in cultured bovine pigmented ciliary epithelial cells. Am J Physiol 1989;256:C44–C49.
14.
Kumagai AK, Glasgow BJ, Pardridge WM: GLUT1 glucose transporter expression in the diabetic and nondiabetic human eye. Invest Ophthalmol Vis Sci 1994;35:2887–2894.
15.
May JM, Qu ZC, Whitesell RR: Ascorbic acid recycling enhances the antioxidant reserve of human erythrocytes. Biochemistry 1995;34:12721–12728.
16.
Hornig B, Arakawa N, Kohler C, Drexler H: Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation 1998;97:363–368.
17.
Keith M, Geranmayegan A, Sole MJ, Kurian R, Robinson A, Omran AS, Jeejeebhoy KN: Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol 1998;31:1352–1356.
18.
Elmoselhi AB, Butcher A, Samson SE, Grover AK: Free radicals uncouple the sodium pump in pig coronary artery. Am J Physiol 1994;266:C720–C728.
19.
Elmoselhi AB, Samson SE, Grover AK: SR Ca2+ pump heterogeneity in coronary artery: Free radicals and IP3-sensitive and -insensitive pools. Am J Physiol 1996;271:C1652–C1659.
20.
Grover AK, Samson SE: Effect of superoxide radical on Ca2+ pumps of coronary artery. Am J Physiol 1988;255:C297–C303.
21.
Grover AK, Samson SE, Fomin VP: Peroxide inactivates calcium pumps in pig coronary artery. Am J Physiol 1992;263:H537–H543.
22.
Grover AK, Samson SE, Fomin VP, Werstiuk ES: Effects of peroxide and superoxide on coronary artery: ANG II response and sarcoplasmic reticulum Ca2+ pump. Am J Physiol 1995;269:C546–C553.
23.
Miller FJJ, Gutterman DD, Rios CD, Heistad DD, Davidson BL: Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Cir Res 1998;82:1298–1305.
24.
Nunes GL, Robinson K, Kalynych A, King SB 3rd, Sgoutas DS, Berk BC: Vitamins C and E inhibit O2-production in the pig coronary artery. Circulation 1997;96:3593–3601.
25.
Grover AK, Samson SE: Peroxide resistance of ER Ca2+ pump in endothelium: Implications to coronary artery function. Am J Physiol 1997;273:C1250–C1258.
26.
Siushansian R, Wilson JX: Ascorbate transport and intracellular concentration in cerebral astrocytes. J Neurochem 1995;65:41–49.
27.
Wilson JX, Dixon SJ, Yu J, Nees S, Tyml K: Ascorbate uptake by microvascular endothelial cells of rat skeletal muscle. Microcirculation 1996;3:211–221.
28.
Siushansian R, Wilson JX: Ascorbate transport and intracellular concentration in cerebral astrocytes. J Neurochem 1995;65:41–49.
29.
Klip A, Paquet MR: glucose transport and glucose transporters in muscle and their metabolic regulation. Diabetes Care 1990;13:228–243.
30.
Webb RC, Bohr DF: Potassium-induced relaxation as an indicator of Na+-K+ ATPase activity in vascular smooth muscle. Blood Vessels 1978;15:198–207.
31.
Hubel CA, Highsmith RF: Endothelin-induced changes in intracellular pH and Ca2+ in coronary smooth muscle: Role of Na(+)-H+ exchange. Biochem J 1995;310:1013–1020.
32.
Miyoshi Y, Nakaya Y, Wakatsuki T, Nakaya S, Fujino K, Saito K, Inoue I: Endothelin blocks ATP-sensitive K+ channels and depolarizes smooth muscle cells of porcine coronary artery. Circ Res 1992;70:612–616.
33.
Wilson JX, Jaworski EM, Kulaga A, Dixon SJ: Substrate regulation of ascorbate transport activity in astrocytes. Neurochem Res 1990;15:1037–1043.
34.
Dixon SJ, Kulaga A, Jaworski EM, Wilson JX: Ascorbate uptake by ROS 17/2.8 osteoblast-like cells: Substrate specificity and sensitivity to transport inhibitors. J Bone Miner Res 1991;6:623–629.
35.
Wilson JX, Dixon SJ: Ascorbic acid transport in mouse and rat astrocytes is reversibly inhibited by furosemide. SITS, and DIDS. Neurochem Res 1989;14:1169–1175.
36.
Voskoboinik I, Soderholm K, Cotgreave IA: Ascorbate and glutathione homeostasis in vascular smooth muscle cells: Cooperation with endothelial cells. Am J Physiol 1998;275:C1031–C1039.
37.
Feltes TF, Seidel CL, Dennison DK, Amick S, Allen JC: Relationship between functional Na+ pumps and mitogenesis in cultured coronary artery smooth muscle cells. Am J Physiol 1993;264:C169–C178.
38.
Kikeri D, Zeidel ML, Ballermann BJ, Brenner BM, Hebert SC: pH regulation and response to AVP in A10 cells differ markedly in the presence vs. absence of CO2-HCO3–. Am J Physiol 1990;259:C471–C483.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.